Literature DB >> 8314955

Prevention and treatment of ovarian hyperstimulation.

J G Schenker1.   

Abstract

Mesh:

Substances:

Year:  1993        PMID: 8314955     DOI: 10.1093/oxfordjournals.humrep.a138115

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  14 in total

Review 1.  The empty follicle syndrome.

Authors:  A Kourtis; D Rousso; D Panidis
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

2.  Expression of vascular endothelial growth factor A during ligand-induced down-regulation of luteinizing hormone receptor in the ovary.

Authors:  M Harada; H Peegel; K M J Menon
Journal:  Mol Cell Endocrinol       Date:  2010-07-07       Impact factor: 4.102

3.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

4.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

Review 5.  The pathogenesis of ovarian hyperstimulation syndrome: a continuing enigma.

Authors:  A Simon; A Revel; A Hurwitz; N Laufer
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

6.  Outcome of frozen embryo replacement cycles following elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome.

Authors:  A O Awonuga; N Dean; J Zaidi; R U Pittrof; J S Bekir; S L Tan
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

7.  Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome.

Authors:  T Tomazevic; H Meden-Vrtovec
Journal:  J Assist Reprod Genet       Date:  1996-04       Impact factor: 3.412

8.  Recombinant human follicle-stimulating hormone for ovulation induction in polycystic ovary syndrome: a prospective, randomized trial of two starting doses in a chronic low-dose step-up protocol.

Authors:  J Balasch; F Fábregues; M Creus; R Casamitjana; B Puerto; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

Review 9.  The pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome.

Authors:  Lisa C Grossman; Konstantinos G Michalakis; Hyacinth Browne; Mark D Payson; James H Segars
Journal:  Fertil Steril       Date:  2010-09       Impact factor: 7.329

10.  GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.

Authors:  Kathleen E O'Neill; Suneeta Senapati; Ivy Maina; Clarisa Gracia; Anuja Dokras
Journal:  J Assist Reprod Genet       Date:  2016-06-27       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.